Granite Investment Partners’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-47,998
Closed -$2.12M 284
2020
Q2
$2.12M Sell
47,998
-14,671
-23% -$547K 0.1% 173
2020
Q1
$2.25M Buy
62,669
+23,780
+61% +$1.35M 0.15% 146
2019
Q4
$2.76M Buy
38,889
+8,068
+26% +$585K 0.13% 162
2019
Q3
$2.31M Buy
30,821
+8,172
+36% +$693K 0.12% 149
2019
Q2
$1.83M Buy
22,649
+7,833
+53% +$551K 0.1% 157
2019
Q1
$991K Buy
14,816
+7,249
+96% +$549K 0.06% 226
2018
Q4
$563K Buy
+7,567
New +$625K 0.04% 239

Other funds holding CMD

Granite Investment Partners's CMD Position: Q3 2020 in Review

Granite Investment Partners sold out of Cantel Medical Corporation (CMD) in Q3 2020, closing a stake of 47,998 shares — an estimated $2.12M sold.

Granite Investment Partners first reported a position in CMD in Q4 2018 and held it in 7 quarters. The position peaked at $2.76M in Q4 2019. 196 funds tracked by Wall St. Rank hold CMD as of Q3 2020.

  • Granite Investment Partners reported no remaining Cantel Medical Corporation position as of Q3 2020 after selling out during the quarter.
  • Granite Investment Partners sold 47,998 Cantel Medical Corporation shares in Q3 2020, an estimated $2.12M.
  • Granite Investment Partners first reported a position in Cantel Medical Corporation in Q4 2018 and held it in 7 quarters.
  • Granite Investment Partners's Cantel Medical Corporation position peaked at $2.76M in Q4 2019.
  • 196 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2020.

Based on Granite Investment Partners's 13F filing for Q3 2020, filed 6 Nov 2020.